IMBRIA PHARMACEUTICALS
Dead / Abandoned — Abandoned — express abandonment (as of 29 Jul 2019)
What this means for you
This application is over — abandoned 26 Jul 2019. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88399984
- Mark type
- Design + words
- Filed
- 24 Apr 2019
- Abandoned
- 26 Jul 2019
- Attorney of record
- Mark S. Leonardo
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for treatment of mitochondrial disorders, genetic diseases, cardiovascular diseases, neurological diseases, renal diseases, and blood diseases
- Class 042 — Scientific and technological services: Research and development for pharmaceuticals
Owner
- Imbria Pharmaceuticals, Inc., Boston, MA, US
Prosecution history
- 29 Jul 2019 — ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT
- 29 Jul 2019 — ABANDONMENT - EXPRESS MAILED
- 26 Jul 2019 — TEAS EXPRESS ABANDONMENT RECEIVED
- 12 Jul 2019 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 12 Jul 2019 — NON-FINAL ACTION E-MAILED
- 12 Jul 2019 — NON-FINAL ACTION WRITTEN
- 04 Jul 2019 — ASSIGNED TO EXAMINER
- 10 May 2019 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 09 May 2019 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 27 Apr 2019 — NEW APPLICATION ENTERED